openPR Logo
Press release

11th International Conference on Vascular Dementia

10-16-2018 09:41 AM CET | Health & Medicine

Press release from: Europe Conference

Vascular Dementia 2019

Vascular Dementia 2019

Can We Cure Dementia, Vascular Dementia and Alzheimer's disease?
It’s our pleasure to invite all the participants from all over the world to attend the 11th International Conference on Vascular Dementia which is held during February 15-16, 2019 Amsterdam| Netherlands.
Vascular Dementia conference will assemble illustrious speakers, Researchers, Nobel laureates, Neurologists, and Neuroscience researchers from both academic and health care professionals will join this event to discuss their views and research. The Neurology event will be organized by world Neuroscience and Neurology experts for conducting symposiums, B2B meetings, and workshops will also be conducted on the field of Vascular Dementia, Alzheimer's disease and Aging.
Effective content from Market Analysis:
Why Amsterdam:
Neurodegenerative disorders, particularly Alzheimer’s disease (AD), other forms of dementia and Parkinson’s disease (PD), are among the biggest health care challenges of the 21st century. There are now over 250,000 dementia patients and 40,000 patients of Parkinson’s disease in the Netherlands. Because no treatments can stop these neurodegenerative disorders amid the backdrop of an aging population, numbers are expected to rise further quickly. This poses a direct threat to the sustainability of our entire health care system. The development of treatments that stop, prevent or at least slow down the degenerative processes is crucial to reduce future costs associated with neurodegenerative disorders and hence keep our health care system viable.
Tourist Attraction:
Amsterdam is the Netherlands’ capital it has a population of about 851,373 within the city proper, and 1,351,587 in the urban area and 2,410,960 in the Amsterdam metropolitan area. As per the period of 2010–2012, annually 34,681 patients visited the ED due to the TBI, comprising about 4% of the total injury-related ED visits per year in Netherlands. The overall incidence rate of ED visits due to TBI was 213.6 per 100,000 person years, 241.9 for males, 175.3 for females. Incidence rates were highest in children 268.2, young adults 271.6 and older patients 75–84 years 307.6 or 85 and older 578.2. The estimated total costs of TBI in Netherlands were about €314.6 million per year.
Conference Highlights
• Dementia
• Vascular Dementia
• Lewy body Dementia
• Amyloid Imaging in Dementia
• Alzheimers Disease
• Neurodegenerative Diseases
• Brain Diseases
• Ageing and Dementia
• Dementia Care Management
• Dementia Nursing
• Treating Dementia
• Neuropharmacology
• Novel Therapeutics
• Animal Models in Dementia
• Neuro Oncology and CNS

This live event is looking for new approaches and scopes to thoroughly review the scientific as well as clinical aspect of addiction. Join with more than 500 colleagues for interactive, innovative and incredible experience in beautiful city of Amsterdam, Netherlands

Learning Objectives

1. Share and describe new developments in the field of dementia
2. They can compare research guidelines and good practices with new current practices and strength or gaps
3. Discover new research techniques in development with practical implication used in recovery treatment or research fields
4. Participants can build their networks of professionals and can find valuable resources
5. Explain recent or upcoming changes in policy to identify provider involvement areas
6. Demonstrate the knowledge while treating patients with Alzheimer's disease in clinical aspects
7. Usage of various patient screening tools that used to identify usage of substance abuse and interpretation results
8. Enhance patient’s readiness to change in their risky behaviour’s by using motivational interviewing
9. Also will be offer referral in regards to behavioural interventions which include support groups as well as mutual groups that will assist in recovery process

Participation Benefits:

Welcome Reception
Keynote Presentation
Presentation over concurrent streams
Half day Workshop
Poster Presentation
Video/ Virtual Presentation
Exhibitor and Sponsor displays
Symposium and Networking
Best Poster Award
Young Researcher Award

Who Will Attend

We welcome all the participants from professionals as well as student and delegate whoever is dedicated in increasing the quality improvement in the field of Vascular Dementia, Alzheimer's disease and Aging, includes:

• Psychiatrist
• Neurologist
• Researchers
• Academics
• Recovery & Clinical Service Managers
• Occupational Therapist
• Social Workers
• Therapy and Care Advisors
• Treatment Managers

Why to attend??
Vascular Dementia Conference is a unique forum to bring together worldwide distinguished academics in the field of Neuroscience and Neurology, Nutrition, Researchers, Public health professionals, Scientists, Academic scientists, Industry researchers, Scholars to exchange about state of the Research and Development.
Aim of this conference is stimulate new ideas for treatment that will be beneficial across the spectrum of Vascular Dementia. A Unique Opportunity for Advertisers and Sponsors at this International event.

International SUPPORTED Journals:

1. Journal of Alzheimers Disease & Parkinsonism
2. Journal of Neurological Disorders
3. Brain Disorders & Therapy

Website: https://vasculardementia.conferenceseries.com/

Direct Call: +44 203-936-3178

Europe Conference meetings International is the world’s leading specialist in organizing high quality conferences, meetings, workshops and symposia in all major fields of science, technology and medicine.

Rose Watson | Program Manager
Vascular Dementia 2019 | Neuroscience Conferences
47 Churchfield Road, London, W3 6AY
Tel: +44-203-936-3178

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release 11th International Conference on Vascular Dementia here

News-ID: 1305219 • Views:

More Releases for Dementia

Dementia Care APP Market Is Booming Worldwide 2021-2027 | Dementia Digital Diary …
Global Dementia Care APP market 2020-2026 in-depth study accumulated to supply latest insights concerning acute options. The report contains different predictions associated with Dementia Care APP market size, revenue, production, CAGR, consumption, profit margin, price, and different substantial factors. Whereas accentuation the key driving and Dementia Care APP restraining forces for this market, the report offers trends and developments. It additionally examines the role of the leading
12-19-2019 | Health & Medicine
DST
Dementia screening and prevention – hope or hype?
It is estimated that about 50% of dementia patients do not receive a formal diagnosis. And when the diagnosis is made, it often happens at a time when the disease is well advanced and brain damages are irreversible. A major reason for this is that systematic dementia screening and prevention programmes are not yet ready for implementation as large-scale public health interventions. A key reason for this is the desire
Dementia Treatment
Dementia Drugs and Treatment Market describes its growth, size, share, Forecast and trends to 2025 The global Dementia Drugs and Treatment market is valued at 13900 million US$ in 2018 is expected to reach 26500 million US$ by the end of 2025, growing at a CAGR of 8.4% during 2019-2025. This report focuses on Dementia Drugs volume and value at global level, regional level and company level. From a global perspective, this
12-11-2018 | Health & Medicine
DST
New App detects dementia risks early
• The App is certified as a Medical Device. • Early stages are reliably detected, before the brain damage becomes irreversible. • Sensitivity above 96%, significantly higher than with the established tests (e.g., MMSE 71%). • Now available for free during pre-launch. Dementia is a rapidly increasing social problem of a rapidly aging society. Because until today there is no effective therapy for advanced stages of dementia. Therefore, effective screening tests are needed to detect early stages
2nd International Conference on Dementia and Dementia Care
Breakthrough in Dementia Research and Care Event Name: 2nd International Conference on Dementia and Dementia Care (Dementia 2019) Theme: Breakthrough in Dementia Research and Care Aim and Scope: Dementia is an umbrella term used to describe a set of symptoms that occur when the brain is affected by disease. There’s currently no cure and no treatment that slows or stops its progression, but there are things you can do to help reduce the
2nd International conference on Dementia and Dementia Care
Breakthrough in Dementia Research and Care Event Name: 2nd International Conference on Dementia and Dementia Care (Dementia 2019) Theme: Breakthrough in Dementia Research and Care Aim and Scope: Dementia is an umbrella term used to describe a set of symptoms that occur when the brain is affected by disease. There’s currently no cure and no treatment that slows or stops its progression, but there are things you can do to help reduce the